top of page
Now Offering No-Cost Clinical Autoantibody Testing — through the STOP T1D Screening Program
STOP T1D offers health care providers access to clinical autoantibody testing through the Barbara Davis Center for Diabetes (BDC) Autoantibody Laboratory — with NO COST to your practice or your patients.*
Bring Early Type 1 Diabetes Screening into Your Practice
1
Collect Sample
2
Ship to BDC
3
Receive Results
Participating providers collect a small blood sample and ship it directly to the BDC Autoantibody Laboratory. Testing is performed using a highly sensitive electrochemiluminescence (ECL) assay to detect type 1 diabetes autoantibodies (GAD, IA-2, insulin, ZnT8), and the tissue transglutaminase autoantibody (TG) — a marker of celiac disease. Results are returned within 1–2 weeks to the requesting provider.
* Funding support available now through 12/31/26. Practices are responsible for supplies, sample collection and shipping.
Getting Started is Easy
1. Fill out this form to initiate enrollment in this program.
2. A STOP T1D team member will reach out to schedule a call.
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.
This program was developed independently by the Barbara Davis Center for Diabetes and supported in part by a grant from Sanofi US.
Version 3.5_03.2026 / Design/Website: GSU
bottom of page